ArticleWorld journal of surgical oncology2025
Loss of neuromonitoring signal in thyroid surgery: predictive factors and surgical strategies.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectives1- To assess the predictive factors of loss of neuromonitoring signal (LOS) during thyroid surgery and its possible impact on the risk of recurrent laryngeal nerve palsy (RLNP) and 2- to analyze the potential changes in the surgical strategy induced by LOS during surgery.
methodsThis was a retrospective analysis of the medical records of all patients who underwent hemithyroidectomy (HT) or total thyroidectomy (TT) at our institution between 2005 and 2023. Predictive factors of LOS and RLNP were evaluated via univariate and multivariate analyses.
resultsA total of 114 patients (3.4%) experienced unilateral LOS during surgery, and 54 of them developed RLNP (positive predictive value of LOS = 41%). Multivariate analysis revealed that male sex (odds ratio: OR = 2.64; 95% confidence interval: CI = 1.45–4.76) and TT (OR = 1.76; 95% CI = 1.14–2.77) were independently associated with a greater risk of LOS but had no impact on the risk of RLNP. Among the 58 patients who experienced LOS at the end of the first side in a planned TT, surgery was discontinued in 4 patients (4 with postoperative RLNP) and pursued in 48 patients (25 patients with thyroid cancer).
conclusionTT and male sex were independent risk factors for LOS but were not associated with a higher risk of RLNP in this series. When LOS occurs during a planned TT, the surgeon should consider the risk of true RLN injury and the nature of thyroid disease justifying the removal of the contralateral lobe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.